Joint investor meeting with 2cureX on April 30
On April 30 Scandion Oncology and 2cureX hosted a joint investor arrangement at Symbion.
Sedermera (Denmark) was invited as moderator and presented their business model and track record.
A very positive investor meeting and lively discussion due to lots of good questions.
Thanks to all participants.